Genmab A/S Stock

Genmab A/S EBITDA per Share

The EBITDA per Share of Genmab A/S (GMAB.CO) as of Aug 7, 2026 is 21.09 USD. In the previous year, EBITDA per Share was 16.58 USD — a change of 27.16% (higher).

EBITDA per Share

21.09USD

YoY

27.16%

Last updated:

EBITDA per Share of Genmab A/S is 2026 21.09 USD. EBITDA per Share of Genmab A/S was 2025 16.58 USD. It decreases by 27.16% higher compared to the previous year.
Access this data via the Eulerpool API
Get Free API Key

Genmab A/S Stock analysis

What does Genmab A/S do? Genmab A/S is a Danish biotechnology company specializing in the discovery and development of antibody therapies for cancer and other serious diseases. The company was founded in 1999 and is headquartered in Copenhagen, Denmark. Genmab A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab A/S stock

EBITDA per Share of Genmab A/S is 21.09 USD in 2026.

EBITDA per Share of Genmab A/S changed from 16.58 USD to 21.09 USD, representing a 27.16% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Genmab A/S since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Genmab A/S

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Genmab A/S